Nasal spray shown to be effective in reducing COVID-19 transmission
SHARES
The algae-derived Nasitrol
TM nasal spray reduced the incidence of COVID-19 in intensive care unit (ICU) workers to one percent in a clinical trial.
According to Amcyte Pharma, its Nasitrol
TM nasal spray was shown to be effective in reducing COVID-19 infections among intensive care unit (ICU) staff in an independent clinical trial.
Nasitrol is a patented nasal spray based on iota carrageenan, a sulfate polysaccharide synthesised by red algae, with demonstrated antiviral activity and clinical efficacy as a nasal spray in the treatment of the common cold. A previous study at the US’s University of Tennessee Health Science Center found that the formulation inhibits infection by SARS-CoV-2, the virus that causes COVID-19,
Share:
GERMANTOWN, Tenn., May 3, 2021 /PRNewswire-PRWeb/ Born in London, Dr. Purvisha Patel was raised in Wales (United Kingdom) and Virginia. She completed her undergraduate and medical school studies at the University of Virginia. She completed her dermatology training at The University of Tennessee Health Science Center in Memphis. During residency, Dr. Patel discovered her passion for treating skin cancer and anti-aging and went on to complete a surgical fellowship under the tutelage of Dr. Michael McCall at the University of Louisville in Kentucky. Dr. Patel is certified by the American Board of Dermatology and is a member of the American Academy of Dermatology and the American Society for Dermatologic Surgery. She is a fellow of the American College of Mohs Micrographic Surgery and Cutaneous Oncology and serves as a clinical professor of the University of Tennessee Department of Dermatology. Dr. Patel s expertise in skin and skincare is also seen as she formulated and paten
Published: May 03, 2021
KIRKLAND, WA – May 3, 2021 Amcyte Pharma, a Seattle-based company dedicated to the commercialization of immunomodulators, announced the results of an independent clinical trial among ICU staff suggesting that its product, Nasitrol
TM nasal spray, represents a safe and effective treatment that could prevent transmission of COVID-19. Amcyte will market Nasitrol in the U.S. through a licensing agreement from Laboratorio Pablo Cassara, an Argentinean pharma company leader in innovation.
Nasitrol is a patented nasal spray based on iota carrageenan, a sulfate polysaccharide synthesized by red algae, with demonstrated antiviral activity and clinical efficacy as a nasal spray in the treatment of the common cold. A previous study at the University of Tennessee Health Science Center found that the iota carrageenan formulation inhibits infection by SARS-CoV-2, the virus that causes COVID-19, in cell culture in vitro.
In March 70 people were laid off from UTHSC. Author: Local 24 Staff (Local 24) Published: 10:56 PM CDT May 1, 2021 Updated: 10:56 PM CDT May 1, 2021
MEMPHIS, Tenn. May 1st is recognized as International Workers Day.
Concerned workers gathered to let their voices be heard about reversing the lay-offs at University of Tennessee Health Science Center on Saturday afternoon.
In March 70 people were laid off from UTHSC.
Local 24 News spoke with one man who says he worked there for 20 years and was let go on the same day he celebrated that accomplishment. With all this pandemic going on we as workers still was coming out putting our lives on the line working. Then put our families lives on the line because we had to work then come home to our families, said laid-off UTHSC worker, Tony Patton.